Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets

This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 17/140/02) and is published in full in <i>Health Technology Assessment</i>; Vol. 28, No. 79. See the NIHR Funding and Awards website for further award information.

Authors

Institutions

Publication Details

Journal
Health Technology Assessment
Published
2024-12-01
DOI
https://doi.org/10.3310/kdap7034
Citations
3
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
3.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets

ANTHONY C. KEECH, John Robson, Jane Armitage, Alastair Gray et al.
3 citations
Health Technology Assessment
Health Systems, Economic Evaluations, Quality of Life
3.39
article

Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets

ANTHONY C. KEECH, John Robson, Jane Armitage, Alastair Gray, Colin Baigent, Jonathan Emberson, Richard J. Parnell, Claire Williams, Christina Reith, Borislava Mihaylova, John Simes, Runguo Wu, Iryna Schlackow, Junwen Zhou
article en
3 citations

Abstract

This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 17/140/02) and is published in full in <i>Health Technology Assessment</i>; Vol. 28, No. 79. See the NIHR Funding and Awards website for further award information.

Health Technology AssessmentVol. 28(79)
The University of Sydney (AU), Queen Mary University of London (GB), University of Oxford (GB), National Health and Medical Research Council (AU)
Abbott Laboratories, Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Barts Charity, Mylan, National Institute for Health and Care Research, British Heart Foundation, Department of Health and Social Care, European Society of Cardiology, Medical Research Council, Health Technology Assessment Programme, National Health and Medical Research Council, Programme Grants for Applied Research
Partnerships for the goals
Openalex Percentile: Top 6%
Health Systems, Economic Evaluations, Quality of Life
3.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.